Universal Beteiligungs und Servicegesellschaft mbH Acquires New Position in Henry Schein, Inc. (NASDAQ:HSIC)

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 82,986 shares of the company's stock, valued at approximately $5,743,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.07% of Henry Schein as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Investment Management Corp VA ADV acquired a new position in Henry Schein during the 4th quarter valued at about $32,000. Venturi Wealth Management LLC increased its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC raised its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after buying an additional 323 shares during the last quarter. Smartleaf Asset Management LLC boosted its position in shares of Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares during the period. Finally, Allworth Financial LP grew its holdings in Henry Schein by 180.7% in the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock worth $71,000 after buying an additional 609 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Price Performance

Shares of NASDAQ:HSIC traded down $0.18 during trading hours on Wednesday, hitting $70.39. 1,210,614 shares of the company's stock traded hands, compared to its average volume of 1,683,392. The company's fifty day simple moving average is $67.71 and its two-hundred day simple moving average is $71.68. The company has a market cap of $8.57 billion, a price-to-earnings ratio of 28.97, a price-to-earnings-growth ratio of 2.13 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the company earned $1.10 EPS. The business's revenue for the quarter was down .1% compared to the same quarter last year. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Activity

In other news, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now owns 62,688 shares of the company's stock, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total value of $184,988.16. Following the transaction, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50% decrease in their position. The disclosure for this sale can be found here. 1.08% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several research firms recently commented on HSIC. UBS Group lowered their target price on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Piper Sandler lowered their price target on Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Barrington Research decreased their target price on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research report on Tuesday, May 6th. Finally, Wall Street Zen downgraded shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Henry Schein presently has a consensus rating of "Moderate Buy" and an average target price of $79.30.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.